Douglas Neeld, MD
Allergy & Immunology (Internal Medicine) Physician in Fort Wayne, Indiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 517 in Allergy & Immunology (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Douglas Neeld, MD reported a CMS MIPS final score of 81.2/100 - below the 83.1 national average - and filed 1,220 Medicare Part D claims in 2023.
- 81.2/100
- MIPS score · -2 vs avg
- 1K
- Part D claims, 2023
- 47%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Douglas Neeld, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
81 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Douglas Neeld, MD sits
This provider among allergy & immunology (internal medicine) physician peers
Across the 130 allergy & immunology (internal medicine) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Douglas Neeld, MD writes more Part D claims than 85% of them and scores higher on MIPS quality than 50% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one allergy & immunology (internal medicine) physician peer from a representative sample of 60; the gold marker is Douglas Neeld, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Douglas Neeld, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Douglas Neeld, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Allergy & Immunology (Internal Medicine) Physician compares to other specialties among Indiana providers
Allergy & Immunology (Internal Medicine) Physician ranks #322 among Indiana's specialties (0% of in-state providers)
Each bar is a specialty's share of the Indiana provider total, by primary NUCC taxonomy. The highlighted bar is Allergy & Immunology (Internal Medicine) Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Douglas Neeld, MD's 2023 MIPS final score plotted against the Allergy & Immunology (Internal Medicine) Physician national average
- MIPS Final Score
- 81.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy & Immunology (Internal Medicine) Physician) - 81.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Allergy & Immunology (Internal Medicine) Physician US NPIs
81.2/100 MIPS final score - 1.9 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Allergy & Immunology (Internal Medicine) Physician. Quality dim: 69. Cost dim: 68.5.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Douglas Neeld, MD appears in the CMS NPPES registry as an Allergy & Immunology (Internal Medicine) Physician provider holding MD credentials at 11104 PARKVIEW CIRCLE DR STE 10, Fort Wayne, IN, 46845, with a listed phone of (260) 425-6070. NPI 1780669374 was issued on 12/07/2005.
Medicare Part D records for calendar year 2023 show 1,220 prescription claims written by this provider, covering 195 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 53% brand-name and 47% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.2/100 for the 2023 performance year (Quality 69, Cost 68.5), compared with the national average of 83.1.
Allergy & Immunology (Internal Medicine) Physician is a narrow specialty nationwide, with 517 enrolled providers across 47 states and an average of 798 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1780669374 |
|---|---|
| Specialty | Allergy & Immunology (Internal Medicine) Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 12/07/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Douglas Neeld, MD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1780669374 is the unique 10-digit identifier CMS uses to link Neeld across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Douglas Neeld, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Douglas Neeld, MD. Source: openpaymentsdata.cms.gov.
Total received
$10.7K
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
53% brand-name claims vs 47% generic, on 1,220 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,021
- Total Day Supply
- 58,807
- Brand vs Generic
- 53% brand / 47% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $24K
- Antibiotic Claims
- 23
Patient Demographics
- Average Patient Age
- 69.2 years
- Avg HCC Risk Score
- 1.24
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Douglas Neeld, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
193 claims
- Trelegy Ellipta
Trelegy Ellipta
119 claims
- Advair Hfa 64
Advair Hfa
64 claims
- Spiriva Respimat 63
Spiriva Respimat
63 claims
- Breo Ellipta 61
Breo Ellipta
61 claims
- Albuterol Sulfate … 55
Albuterol Sulfate Hfa
55 claims
- Ipratropium Bromide 49
Ipratropium Bromide
49 claims
- Fluticasone Propio… 46
Fluticasone Propionate
46 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 193 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 119 |
| Advair Hfa Fluticasone Propion/Salmeterol | 64 |
| Spiriva Respimat Tiotropium Bromide | 63 |
| Breo Ellipta Fluticasone/Vilanterol | 61 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 55 |
| Ipratropium Bromide | 49 |
| Fluticasone Propionate | 46 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 45 |
| Azelastine Hcl | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology (Internal Medicine) Physician Overview
How Douglas Neeld, MD fits within the Allergy & Immunology (Internal Medicine) Physician landscape nationally.
Douglas Neeld, MD's 1,220 claims are above the specialty average of 798.
Nearby Allergy & Immunology (Internal Medicine) Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Neeld.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Indiana medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Allergy & Immunology (Internal Medicine) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is Douglas Neeld, MD's specialty? ▼
How much does Douglas Neeld, MD prescribe under Medicare Part D? ▼
What is Douglas Neeld, MD's Medicare quality score? ▼
Where is Douglas Neeld, MD located? ▼
What is Douglas Neeld, MD's NPI number? ▼
Does Douglas Neeld, MD prescribe more brand-name or generic drugs? ▼
How many Allergy & Immunology (Internal Medicine) Physician providers are there in the US? ▼
What drugs does Douglas Neeld, MD prescribe most often? ▼
Does Douglas Neeld, MD accept Medicare? ▼
How can I verify Douglas Neeld, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.